Biomarker for endometrial cancer and application thereof
The invention provides a biomarker for indicating endometrial cancer. The biomarker comprises one or any composition of the following lncRNAs (long non-coding ribonucleic acid): LOC100190940, C20orf56, LOC100144604, LOC151534, LOC727677, FLJ35390 and LOC158572. The biomarker can be used for detectin...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention provides a biomarker for indicating endometrial cancer. The biomarker comprises one or any composition of the following lncRNAs (long non-coding ribonucleic acid): LOC100190940, C20orf56, LOC100144604, LOC151534, LOC727677, FLJ35390 and LOC158572. The biomarker can be used for detecting endometrial cancer. The invention also provides a method for diagnosing endometrial cancer by using the biomarker. The invention also provides a kit and a gene chip which contain the biomarker and are used for diagnosing endometrial cancer, and a preparation method of the kit and the gene chip.
本发明提供了表明子宫内膜癌的生物标记物,所述标记物包括以下lncRNA中的一个或其任意组合物:LOC100190940、C20orf56、LOC100144604、LOC151534、LOC727677、FLJ35390和LOC158572。本发明还提供了采用所述生物标记物诊断子宫内膜癌的方法。本发明还提供了包含所述生物标记物的诊断子宫内膜癌的试剂盒和基因芯片,及其制备方法。 |
---|